MIDTERM: OTHER INTESTINAL PROTOZOANS Flashcards
- causes BLASTOCYSTOSIS
- previously classified as yeast under the genus Schizosaccharomyces
- taxonomists suggested that it was related to Blastomyces
o due to glistening appearance in a wet mount and the absence of any
organelle of locomotion
o capable of pseudopodial extension and retraction
o responds to anti-protozoal drugs
Blastocystis hominis
Morphological forms of B. hominis:
o MOST PREDOMINANT FORMS in fecal specimens
o Shape: spherical
o Size: 5-10um in diameter
o large central vacuole pushes the cytoplasm and the four nuclei to the periphery of the cell
o sometimes, very thick capsule surrounds the vacuolated forms
o Reproductive organelle: prominent central vacuole
o main type of Blastocystis that cause diarrhea
Vacuolated
Morphological forms of B. hominis:
o Size: 2.5-8um
o occasionally observed in stool samples
o exhibit active extension and retraction of pseudopodia.
o Visible Nuclear Chromatin: shows peripheral clumping
o INTERMEDIATE STAGE between the vacuolar form and the precystic form
o allows the parasite to ingest bacteria in order to enhance encystment
Ameba-like forms
Morphological forms of B. hominis:
o MULTINUCLEATED
o Mainly observed from old cultures
o Size: 10-60um
o Granular contents: develop into daughter cells of the ameba-form when the cell ruptures
Granular forms
Morphological forms of B. hominis:
o arise from vacuolated forms
o believed to produce many vacuolated forms.
o RESISTANT CYSTIC FORM: 3 to 10 μm in diameter, has 1 or 2 nuclei
o very prominent and thick, osmophilic, electron dense wall
o appears as a sharply demarcated polymorphic, but mostly oval or circular, dense body surrounded by a loose outer membranous layer.
Multiple Fission
o responsible for EXTERNAL TRANSMISSION
B. hominis Thick-walled cyst
may be the cause of REINFECTION within a host’s intestinal tract
B. hominis Thin-walled cyst
Blastocystis is difficult to eradicate
T OR F?
TRUE
o Hides in intestinal mucus
o Sticks and holds on to intestinal membranes
drug of choice
o METRONIDAZOLE given orally, 750 mg
three times daily for 10 days
o (Pediatric dose: 35-50 mg/kg/day in
three doses for 5 days)
o IODOQUINOL given at 650 mg three
times daily for 20 days
found to resolve symptoms in 86% of patients after 3 days of administration
Nitazoxanide
first discovered Dientamoeba fragilis in 1909
Wenyon
o first described in the scientific literature in 1918
Jepps and Dobell
- originally described as an ameba
- a flagellate (only the trophozoite stage known)
- NO CYST STAGE
- closely related to and resembles Trichomonas
- Location: lives in the mucosal crypts of the appendix, cecum and the upper colon
- Transmission: Direct human to human transmission is probably via the fecal-oral route or via transmission of helminth eggs particularly that of Enterobius vermicularis
- Dientamoeba-like mononucleated and binucleated forms have been observed in the lumen of Enterobius
- Animal Reservoirs: macaques, gorillas, and swine
- CAPABLE OF CO-INFECTION WITH Enterobius
Dientamoeba fragilis
- size: 7 to 12 µm with one or two (rarely three or four) ROSETTE-shaped nuclei
- Nuclear Membrane: no peripheral chromatin
- Karyosome: four to six discrete granules
- Cytoplasm: may contain vacuoles with ingested debris
Dientamoeba fragilis TROPHOZOITE
Dientamoeba fragilis DIAGNOSIS:
- provide more suitable material for examination than the average formed stool
Purged stool specimens